Literature DB >> 25003191

RAS interaction with PI3K p110α is required for tumor-induced angiogenesis.

Miguel Manuel Murillo, Santiago Zelenay, Emma Nye, Esther Castellano, Francois Lassailly, Gordon Stamp, Julian Downward.   

Abstract

Direct interaction of RAS with the PI3K p110α subunit mediates RAS-driven tumor development: however, it is not clear how p110α/RAS-dependant signaling mediates interactions between tumors and host tissues. Here, using a murine tumor cell transfer model, we demonstrated that disruption of the interaction between RAS and p110α within host tissue reduced tumor growth and tumor-induced angiogenesis, leading to improved survival of tumor-bearing mice, even when this interaction was intact in the transferred tumor. Furthermore, functional interaction of RAS with p110α in host tissue was required for efficient establishment and growth of metastatic tumors. Inhibition of RAS and p110α interaction prevented proper VEGF-A and FGF-2 signaling, which are required for efficient angiogenesis. Additionally, disruption of the RAS and p110α interaction altered the nature of tumor-associated macrophages, inducing expression of markers typical for macrophage populations with reduced tumor-promoting capacity. Together, these results indicate that a functional RAS interaction with PI3K p110α in host tissue is required for the establishment of a growth-permissive environment for the tumor, particularly for tumor-induced angiogenesis. Targeting the interaction of RAS with PI3K has the potential to impair tumor formation by altering the tumor-host relationship, in addition to previously described tumor cell-autonomous effects.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25003191      PMCID: PMC4109531          DOI: 10.1172/JCI74134

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  51 in total

1.  Neoadjuvant chemotherapy and bevacizumab for HER2-negative breast cancer.

Authors:  Gunter von Minckwitz; Holger Eidtmann; Mahdi Rezai; Peter A Fasching; Hans Tesch; Holm Eggemann; Iris Schrader; Kornelia Kittel; Claus Hanusch; Rolf Kreienberg; Christine Solbach; Bernd Gerber; Christian Jackisch; Georg Kunz; Jens-Uwe Blohmer; Jens Huober; Maik Hauschild; Tanja Fehm; Berit Maria Müller; Carsten Denkert; Sibylle Loibl; Valentina Nekljudova; Michael Untch
Journal:  N Engl J Med       Date:  2012-01-26       Impact factor: 91.245

Review 2.  Tumor angiogenesis: therapeutic implications.

Authors:  J Folkman
Journal:  N Engl J Med       Date:  1971-11-18       Impact factor: 91.245

3.  Phase III study of carboplatin and paclitaxel alone or with sorafenib in advanced non-small-cell lung cancer.

Authors:  Giorgio Scagliotti; Silvia Novello; Joachim von Pawel; Martin Reck; José Rodrigues Pereira; Michael Thomas; José Elias Abrão Miziara; Beatrix Balint; Filippo De Marinis; Alan Keller; Osvaldo Arén; Maria Csollak; Istvan Albert; Carlos Henrique Barrios; Francesco Grossi; Maciej Krzakowski; Lisa Cupit; Frank Cihon; Sandra Dimatteo; Nasser Hanna
Journal:  J Clin Oncol       Date:  2010-03-08       Impact factor: 44.544

Review 4.  RAS oncogenes: weaving a tumorigenic web.

Authors:  Yuliya Pylayeva-Gupta; Elda Grabocka; Dafna Bar-Sagi
Journal:  Nat Rev Cancer       Date:  2011-10-13       Impact factor: 60.716

5.  Activation of phosphoinositide 3-kinase by interaction with Ras and by point mutation.

Authors:  P Rodriguez-Viciana; P H Warne; B Vanhaesebroeck; M D Waterfield; J Downward
Journal:  EMBO J       Date:  1996-05-15       Impact factor: 11.598

Review 6.  Co-evolution of tumor cells and their microenvironment.

Authors:  Kornelia Polyak; Izhak Haviv; Ian G Campbell
Journal:  Trends Genet       Date:  2008-12-04       Impact factor: 11.639

7.  Collaborative interplay between FGF-2 and VEGF-C promotes lymphangiogenesis and metastasis.

Authors:  Renhai Cao; Hong Ji; Ninghan Feng; Yin Zhang; Xiaojuan Yang; Patrik Andersson; Yuping Sun; Katerina Tritsaris; Anker Jon Hansen; Steen Dissing; Yihai Cao
Journal:  Proc Natl Acad Sci U S A       Date:  2012-09-11       Impact factor: 11.205

8.  Distinct role of fibroblast growth factor-2 and vascular endothelial growth factor on tumor growth and angiogenesis.

Authors:  Raffaella Giavazzi; Barbara Sennino; Daniela Coltrini; Angela Garofalo; Romina Dossi; Roberto Ronca; Maria Pia Molinari Tosatti; Marco Presta
Journal:  Am J Pathol       Date:  2003-06       Impact factor: 4.307

9.  IL-12 can target human lung adenocarcinoma cells and normal bronchial epithelial cells surrounding tumor lesions.

Authors:  Irma Airoldi; Emma Di Carlo; Claudia Cocco; Emanuela Caci; Michele Cilli; Carlo Sorrentino; Gabriella Sozzi; Silvano Ferrini; Sandra Rosini; Giulia Bertolini; Mauro Truini; Francesco Grossi; Luis Juan Vicente Galietta; Domenico Ribatti; Vito Pistoia
Journal:  PLoS One       Date:  2009-07-01       Impact factor: 3.240

10.  Requirement for interaction of PI3-kinase p110α with RAS in lung tumor maintenance.

Authors:  Esther Castellano; Clare Sheridan; May Zaw Thin; Emma Nye; Bradley Spencer-Dene; Markus E Diefenbacher; Christopher Moore; Madhu S Kumar; Miguel M Murillo; Eva Grönroos; Francois Lassailly; Gordon Stamp; Julian Downward
Journal:  Cancer Cell       Date:  2013-11-11       Impact factor: 31.743

View more
  36 in total

Review 1.  Drugging Ras GTPase: a comprehensive mechanistic and signaling structural view.

Authors:  Shaoyong Lu; Hyunbum Jang; Shuo Gu; Jian Zhang; Ruth Nussinov
Journal:  Chem Soc Rev       Date:  2016-07-11       Impact factor: 54.564

2.  The structural basis for Ras activation of PI3Kα lipid kinase.

Authors:  Mingzhen Zhang; Hyunbum Jang; Ruth Nussinov
Journal:  Phys Chem Chem Phys       Date:  2019-06-05       Impact factor: 3.676

3.  Differential Role of the RasGEFs Sos1 and Sos2 in Mouse Skin Homeostasis and Carcinogenesis.

Authors:  Pilar Liceras-Boillos; David Jimeno; Rósula García-Navas; L Francisco Lorenzo-Martín; Mauricio Menacho-Marquez; Carmen Segrelles; Carmela Gómez; Nuria Calzada; Rocío Fuentes-Mateos; Jesús M Paramio; Xosé R Bustelo; Fernando C Baltanás; Eugenio Santos
Journal:  Mol Cell Biol       Date:  2018-07-30       Impact factor: 4.272

4.  Tumor-Targeted Synergistic Blockade of MAPK and PI3K from a Layer-by-Layer Nanoparticle.

Authors:  Erik C Dreaden; Yi Wen Kong; Stephen W Morton; Santiago Correa; Ki Young Choi; Kevin E Shopsowitz; Kasper Renggli; Ronny Drapkin; Michael B Yaffe; Paula T Hammond
Journal:  Clin Cancer Res       Date:  2015-06-01       Impact factor: 12.531

5.  IKKβ targeting reduces KRAS-induced lung cancer angiogenesis in vitro and in vivo: A potential anti-angiogenic therapeutic target.

Authors:  Tatiana Correa Carneiro-Lobo; Luiza Coimbra Scalabrini; Leila da Silva Magalhães; Laura B Cardeal; Felipe Silva Rodrigues; Edmilson Ozorio Dos Santos; Albert S Baldwin; Elena Levantini; Ricardo J Giordano; Daniela Sanchez Bassères
Journal:  Lung Cancer       Date:  2019-02-25       Impact factor: 5.705

Review 6.  RAS Proteins and Their Regulators in Human Disease.

Authors:  Dhirendra K Simanshu; Dwight V Nissley; Frank McCormick
Journal:  Cell       Date:  2017-06-29       Impact factor: 41.582

Review 7.  PI3K: A Crucial Piece in the RAS Signaling Puzzle.

Authors:  Agata Adelajda Krygowska; Esther Castellano
Journal:  Cold Spring Harb Perspect Med       Date:  2018-06-01       Impact factor: 6.915

8.  Long-Term ERK Inhibition in KRAS-Mutant Pancreatic Cancer Is Associated with MYC Degradation and Senescence-like Growth Suppression.

Authors:  Tikvah K Hayes; Nicole F Neel; Chaoxin Hu; Prson Gautam; Melissa Chenard; Brian Long; Meraj Aziz; Michelle Kassner; Kirsten L Bryant; Mariaelena Pierobon; Raoud Marayati; Swapnil Kher; Samuel D George; Mai Xu; Andrea Wang-Gillam; Ahmed A Samatar; Anirban Maitra; Krister Wennerberg; Emanuel F Petricoin; Hongwei H Yin; Barry Nelkin; Adrienne D Cox; Jen Jen Yeh; Channing J Der
Journal:  Cancer Cell       Date:  2015-12-24       Impact factor: 31.743

9.  Molecular mechanism of activation of class IA phosphoinositide 3-kinases (PI3Ks) by membrane-localized HRas.

Authors:  Braden D Siempelkamp; Manoj K Rathinaswamy; Meredith L Jenkins; John E Burke
Journal:  J Biol Chem       Date:  2017-05-17       Impact factor: 5.157

Review 10.  Mechanistic regulation of epithelial-to-mesenchymal transition through RAS signaling pathway and therapeutic implications in human cancer.

Authors:  Kiran Tripathi; Minal Garg
Journal:  J Cell Commun Signal       Date:  2018-01-12       Impact factor: 5.782

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.